Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT05856448

Public ClinicalTrials.gov record NCT05856448. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 2:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GLPG3667 in Adult Subjects With Active Systemic Lupus Erythematosus

Study identification

NCT ID
NCT05856448
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Lakefront Biotherapeutics NV
Industry
Enrollment
186 participants

Conditions and interventions

Interventions

  • GLPG3667 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 27, 2023
Primary completion
Oct 7, 2025
Completion
Feb 26, 2026
Last update posted
May 13, 2026

2023 – 2026

United States locations

U.S. sites
22
U.S. states
8
U.S. cities
19
Facility City State ZIP Site status
University of Arizona College of Medicine - Tucson Tucson Arizona 85724
University of California San Diego La Jolla California 92037
Desert Medical Advances Rancho Mirage California 92270
Millennium Clinical Trials Simi Valley California 93064
Inland Rheumatology Clinical Trials Upland California 91786
Upland Rheumatology Center Upland California 91786
Arthritis & Rheumatic Disease Specialties Aventura Florida 33180
Omega Research DeBary DeBary Florida 32713
Alloy Clinical Research, LLC Kissimmee Florida 34741
San Marcus Research Clinic Miami Florida 33014
Advanced Pharma - Miami Miami Florida 33147
Professional Research Center Miami Florida 33172
Integral Rheumatology & Immunology Specialists Plantation Florida 33324
Alliance Clinical Research of Tampa Tampa Florida 33615
Albuquerque Clinical Trials Albuquerque New Mexico 87102
DJL Clinical Research Charlotte North Carolina 28211
Lynn Institute of Tulsa Tulsa Oklahoma 74135
New Phase Research & Development Knoxville Tennessee 37909
Office of Ramesh C. Gupta MD / Shelby Research LLC - Tennessee Memphis Tennessee 38119
Care and Cure Clinic Houston Texas 77090
Southwest Arthritis Mesquite Texas 75150
Sun Research Institute San Antonio Texas 78215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05856448, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05856448 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →